John W. Madigan

John W. Madigan discloses dealings in 2 companies, chiefly Gilead Sciences, Inc. and BOISE CASCADE Co. Over a trading history stretching from 6 May 2010 to 9 May 2017, the count stands at 16 filings.

No open-market purchase appears, only 2 sales worth €19.0M. The rest of the record consists of 1 share grant and 11 option exercises.

Most recently, on 11 May 2017, the filings show an option exercise in Gilead Sciences, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.